Update on unsecured debt facility Paris, France and Camberley, UK – 19 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the
Visit PageCategory: Uncategorized
RESULTS OF ANNUAL GENERAL MEETING
AGM results statement June 2018 Paris, France and Cambridge, UK – 12 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, yesterday held its Annual General Meeting (AGM). The results of the AGM are set out in the table below, with the Company pleased to announce that all resolutions
Visit PageNOVACYT LAUNCHES NEW PRODUCT IN INFECTIOUS MONONUCLEOSIS
New product launch under PathFlow brand First in a series of new product launches in infectious diseases
Visit Page